Kane Biotech (TSE:KNE) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kane Biotech, a company specializing in the development of biofilm-prevention technologies, will release its Q1 2024 financial results on May 23, 2024, after the market closes. A corporate update will follow during the Special and Annual General Meeting via videoconference on May 22. The company is known for its extensive portfolio of biotechnologies and intellectual property, including 67 patents and patents pending.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.